Targeted Migration of Mesenchymal Stem Cells Modified With CXCR4 Gene to Infarcted Myocardium Improves Cardiac Performance

Molecular Therapy - Tập 16 Số 3 - Trang 571-579 - 2008
Zhaokang Cheng1, Lailiang Ou1, Xin Zhou2, Fei Li3, Xiaohua Jia1, Zhang Yinguo2, Xiaolei Liu1, Yuming Li2, Christopher A. Ward4, Luis G. Melo4, Deling Kong1
1Key Laboratory of Bioactive Materials of Ministry of Education, College of Life Science, Nankai University, Tianjin, China;
2Institute of Cardiovascular Disease, Pingjin Hospital, Medical College of Armed Police Forces, Tianjin, China
3Special Consulting Department, No. 254 Hospital of PLA, Tianjin, China
4Department of Physiology, Queen's University, Kingston, Ontario, Canada

Tóm tắt

Từ khóa


Tài liệu tham khảo

Pittenger, 1999, Multilineage potential of adult human mesenchymal stem cells, Science, 284, 143, 10.1126/science.284.5411.143

Jiang, 2002, Pluripotency of mesenchymal stem cells derived from adult marrow, Nature, 418, 41, 10.1038/nature00870

Di Nicola, 2002, Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli, Blood, 99, 3838, 10.1182/blood.V99.10.3838

Dai, 2005, Allogeneic mesenchymal stem cell transplantation in postinfarcted rat myocardium: short- and long-term effects, Circulation, 112, 214, 10.1161/CIRCULATIONAHA.104.527937

Amado, 2005, Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction, Proc Natl Acad Sci USA, 102, 11474, 10.1073/pnas.0504388102

Silva, 2005, Mesenchymal stem cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a canine chronic ischemia model, Circulation, 111, 150, 10.1161/01.CIR.0000151812.86142.45

Tomita, 2002, Improved heart function with myogenesis and angiogenesis after autologous porcine bone marrow stromal cell transplantation, J Thorac Cardiovasc Surg, 123, 1132, 10.1067/mtc.2002.120716

Mangi, 2003, Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts, Nat Med, 9, 1195, 10.1038/nm912

Noiseux, 2006, Mesenchymal stem cells overexpressing Akt dramatically repair infarcted myocardium and improve cardiac function despite infrequent cellular fusion or differentiation, Mol Ther, 14, 840, 10.1016/j.ymthe.2006.05.016

Berry, 2006, Mesenchymal stem cell injection after myocardial infarction improves myocardial compliance, Am J Physiol Heart Circ Physiol, 290, 2003, 10.1152/ajpheart.01017.2005

Davani, 2003, Mesenchymal progenitor cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a rat cellular cardiomyoplasty model, Circulation, 108, II253

Makino, 1999, Cardiomyocytes can be generated from marrow stromal cells in vitro, J Clin Invest, 103, 697, 10.1172/JCI5298

Toma, 2002, Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart, Circulation, 105, 93, 10.1161/hc0102.101442

Kawada, 2004, Nonhematopoietic mesenchymal stem cells can be mobilized and differentiate into cardiomyocytes after myocardial infarction, Blood, 104, 3581, 10.1182/blood-2004-04-1488

Kinnaird, 2004, Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms, Circulation, 109, 1543, 10.1161/01.CIR.0000124062.31102.57

Kinnaird, 2004, Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms, Circ Res, 94, 678, 10.1161/01.RES.0000118601.37875.AC

Jiang, 2006, Supportive interaction between cell survival signaling and angiocompetent factors enhances donor cell survival and promotes angiomyogenesis for cardiac repair, Circ Res, 99, 776, 10.1161/01.RES.0000244687.97719.4f

Gnecchi, 2006, Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement, FASEB J, 20, 661, 10.1096/fj.05-5211com

Uemura, 2006, Bone marrow stem cells prevent left ventricular remodeling of ischemic heart through paracrine signaling, Circ Res, 98, 1414, 10.1161/01.RES.0000225952.61196.39

Barbash, 2003, Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration, and body distribution, Circulation, 108, 863, 10.1161/01.CIR.0000084828.50310.6A

Nagaya, 2004, Intravenous administration of mesenchymal stem cells improves cardiac function in rats with acute myocardial infarction through angiogenesis and myogenesis, Am J Physiol Heart Circ Physiol, 287, H2670, 10.1152/ajpheart.01071.2003

Jiang, 2006, Homing and differentiation of mesenchymal stem cells delivered intravenously to ischemic myocardium in vivo: a time-series study, Pflugers Arch, 453, 43, 10.1007/s00424-006-0117-y

Price, 2006, Intravenous mesenchymal stem cell therapy early after reperfused acute myocardial infarction improves left ventricular function and alters electrophysiologic properties, Int J Cardiol, 111, 231, 10.1016/j.ijcard.2005.07.036

Vandervelde, 2005, Signaling factors in stem cell-mediated repair of infarcted myocardium, J Mol Cell Cardiol, 39, 363, 10.1016/j.yjmcc.2005.05.012

Abbott, 2004, Stromal cell-derived factor-1α plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury, Circulation, 110, 3300, 10.1161/01.CIR.0000147780.30124.CF

Ma, 2005, Time course of myocardial stromal cell-derived factor 1 expression and beneficial effects of intravenously administered bone marrow stem cells in rats with experimental myocardial infarction, Basic Res Cardiol, 100, 217, 10.1007/s00395-005-0521-z

Askari, 2003, Effect of stromal-cell-derived factor-1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy, Lancet, 362, 697, 10.1016/S0140-6736(03)14232-8

Tang, 2005, Mobilizing of haematopoietic stem cells to ischemic myocardium by plasmid mediated stromal-cell-derived factor-1α (SDF-1α) treatment, Regul Pept, 125, 1, 10.1016/j.regpep.2004.10.014

Misao, 2006, Importance of recruitment of bone marrow-derived CXCR4+ cells in post-infarct cardiac repair mediated by G-CSF, Cardiovasc Res, 71, 455, 10.1016/j.cardiores.2006.05.002

Walter, 2005, Impaired CXCR4 signaling contributes to the reduced neovascularization capacity of endothelial progenitor cells from patients with coronary artery disease, Circ Res, 97, 1142, 10.1161/01.RES.0000193596.94936.2c

Brenner, 2004, CXCR4-transgene expression significantly improves marrow engraftment of cultured hematopoietic stem cells, Stem Cells, 22, 1128, 10.1634/stemcells.2003-0196

Wynn, 2004, A small proportion of mesenchymal stem cells strongly expresses functionally active CXCR4 receptor capable of promoting migration to bone marrow, Blood, 104, 2643, 10.1182/blood-2004-02-0526

Peled, 1999, Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4, Science, 283, 845, 10.1126/science.283.5403.845

Honczarenko, 2006, Human bone marrow stromal cells express a distinct set of biologically functional chemokine receptors, Stem Cells, 24, 1030, 10.1634/stemcells.2005-0319

Kahn, 2004, Overexpression of CXCR4 on human CD34+ progenitors increases their proliferation, migration, and NOD/SCID repopulation, Blood, 103, 2942, 10.1182/blood-2003-07-2607

Sordi, 2005, Bone marrow mesenchymal stem cells express a restricted set of functionally active chemokine receptors capable of promoting migration to pancreatic islets, Blood, 106, 419, 10.1182/blood-2004-09-3507

Boomsma, 2007, Intravenously injected mesenchymal stem cells home to viable myocardium after coronary occlusion and preserve systolic function without altering infarct size, Int J Cardiol, 122, 17, 10.1016/j.ijcard.2006.11.022

Bhakta, 2006, The surface adhesion molecule CXCR4 stimulates mesenchymal stem cell migration to stromal cell-derived factor-1, in vitro but does not decrease apoptosis under serum deprivation, Cardiovasc Revasc Med, 7, 19, 10.1016/j.carrev.2005.10.008

Rombouts, 2003, Primary murine MSC show highly efficient homing to the bone marrow but lose homing ability following culture, Leukemia, 17, 160, 10.1038/sj.leu.2402763

Jugdutt, 2003, Ventricular remodeling after infarction and the extracellular collagen matrix: when enough is enough?, Circulation, 108, 1395, 10.1161/01.CIR.0000085658.98621.49

Kucia, 2004, CXCR4-SDF-1 signalling, locomotion, chemotaxis and adhesion, J Mol Histol, 35, 233, 10.1023/B:HIJO.0000032355.66152.b8

Abi-Younes, 2000, The stromal cell-derived factor-1 chemokine is a potent platelet agonist highly expressed in atherosclerotic plaques, Circ Res, 86, 131, 10.1161/01.RES.86.2.131

Zernecke, 2005, SDF-1α/CXCR4 axis is instrumental in neointimal hyperplasia and recruitment of smooth muscle progenitor cells, Circ Res, 96, 784, 10.1161/01.RES.0000162100.52009.38

Sakihama, 2004, Stromal cell-derived factor-1 and CXCR4 interaction is critical for development of transplant arteriosclerosis, Circulation, 110, 2924, 10.1161/01.CIR.0000146890.93172.6C

Kang, 2004, Lancet, 363, 751, 10.1016/S0140-6736(04)15689-4

Burger, 2006, CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment, Blood, 107, 1761, 10.1182/blood-2005-08-3182

Miller, 2001, Hindlimb unloading induces a collagen isoform shift in the soleus muscle of the rat, Am J Physiol Regul Integr Comp Physiol, 281, R1710, 10.1152/ajpregu.2001.281.5.R1710